Emmanuelle Charpentier and Jennifer Doudna leveraged CRISPR into a pair of genetic scissors and showed how sharp they are by proving that they can edit any string of DNA this way. Since Emmanuelle ...

"With the honorary doctorate of the University of Vienna, Emmanuelle Charpentier receives a highly deserved award from the ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9.

Après avoir étudié la biochimie et la microbiologie, les différents post-doctorats d'Emmanuelle Charpentier, puis ses postes de chercheurs et de professeur l’entrainent aux Etats-Unis ...

Emmanuelle Charpentier and Jennifer Doudna leveraged CRISPR into a pair of genetic scissors and showed how sharp they are by proving that they can edit any string of DNA this way. Since Emmanuelle ...

Le mariage de la technique Crispr-Cas9 avec des technologies proches des vaccins à ARN donne des résultats très prometteurs face à une maladie du foie très rare mais mortelle, l’amylose à ...

Le 7 octobre, la généticienne Emmanuelle Charpentier a obtenu le prix Nobel de Chimie aux côtés de l’Américaine Jennifer Doudna, pour leur méthode d’édition du génome Crispr-Cas9.

ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner and Nobel Prize-winner Dr. Emmanuelle Charpentier. The team has decades of ...

Charpentier, and Zhang as the three seminal figures in the development of CRISPR/Cas9 technology: “The attendees are a veritable who’s who of genome editing: Jennifer Doudna of the University of ...

The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug ...